Abstract
Purpose
Understanding practice models and provider costs for medication abortion (MAB) provision
may elucidate ways to facilitate MAB integration into a larger arena of health care
services. This study provides descriptive data on the diverse MAB practice models
currently being utilized by US health care providers and the costs associated with
the components of those models.
Method
Data were gathered from a sample of 11 abortion care settings, using clinic administrative
records and patient satisfaction surveys.
Results
Practice models varied dramatically, with a wide range in the type of staff employed
to provide MAB. The total episode cost for providing MAB ranged from $252 to $460,
and patient satisfaction was high across all practices.
Conclusion
Information from this study can be used to guide decisions regarding MAB integration
into practices not currently providing abortion or which provide only aspiration abortions.
The information may also be useful for providers wishing to refine their MAB services.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to ContraceptionAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Abortion incidence and services in the United States in 2000.Perspect Sex Reprod Health. 2003; 35: 6-15
- For immediate release: July 18, 2005.(from) ([Accessed Dec 15, 2005])
- Medical abortion in family practice: a case series.Am Board Fam Prac. 2003; 16: 290-295
- Willing and able? Provision of medication for abortion by future internists.Women Health Issues. 2005; 15: 39-44
- Normalizing the exceptional: incorporating the ���abortion pill��� into mainstream medicine.Soc Sci Med. 2003; 56: 2353-2366
- Early medical abortion: issues for practice.UCSF Center for Reproductive Health Research & Policy, San Francisco (CA)2001
- Convincing new providers to offer medical abortion: what will it take?.Perspect Sex Reprod Health. 2003; 35: 44-47
- Determinants of physician unwillingness to offer medical abortion using mifepristone.Women Health Issues. 2006; 16: 14-21
- Costs.in: Haddix A.C. Teutsch S.M. Corso P.S. Prevention effectiveness: a guide to decision analysis and economic evaluation. 2nd ed. Oxford University Press, Inc, New York2003: 53-76
- An effective regimen for early medical abortion: a report of 2000 consecutive cases.Hum Reprod. 1998; 13: 2962-2965
- Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.Contraception. 1999; 59: 1-6
- Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions.Am J Obstet Gynecol. 2000; 183: S44-S53
- State policies in brief: mandatory counseling and waiting periods for abortion.(Available at:) ([Accessed February 20, 2006])
- State policies in brief: an overview of abortion laws.(Available at:) ([Accessed: February 20, 2006])
- Acceptability of medical abortion in early pregnancy.Fam Plann Perspect. 1995; 27: 142-185
- Having an abortion using mifepristone and home misoprostol: a qualitative analysis of women's experiences.Perspect Sex Reprod Health. 2002; 34: 34-40
- Pharmacoeconomics of medical abortion: a review of cost in the United States, Europe and Asia.Expert Opin Pharmacother. 2003; 4: 503-513
Article info
Publication history
Published online: November 17, 2006
Accepted:
September 12,
2006
Received in revised form:
September 8,
2006
Received:
March 17,
2006
Identification
Copyright
© 2007 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
